Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Global Outlook and Forecast 2025-2030

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment
1.2 Key Market Segments
1.2.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Segment by Type
1.2.2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Competitive Landscape
3.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales by Manufacturers (2019-2024)
3.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales Sites, Area Served, Product Type
3.6 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Competitive Situation and Trends
3.6.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Industry Chain Analysis
4.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales Market Share by Type (2019-2024)
6.3 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Price by Type (2019-2024)
7 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Sales by Application (2019-2024)
7.3 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales Growth Rate by Application (2019-2024)
8 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Consumption by Region
8.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales by Region
8.1.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales by Region
8.1.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Production by Region
9.1 Global Production of Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment by Region (2019-2024)
9.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Revenue Market Share by Region (2019-2024)
9.3 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production
9.4.1 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Growth Rate (2019-2024)
9.4.2 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production
9.5.1 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Growth Rate (2019-2024)
9.5.2 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2019-2024)
9.6.1 Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Growth Rate (2019-2024)
9.6.2 Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production (2019-2024)
9.7.1 China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production Growth Rate (2019-2024)
9.7.2 China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Production, Revenue, Price and Gross Margin (2019-2024)
10 Key Companies Profile
10.1 Amoun Pharmaceuticals
10.1.1 Amoun Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Basic Information
10.1.2 Amoun Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Overview
10.1.3 Amoun Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Market Performance
10.1.4 Amoun Pharmaceuticals Business Overview
10.1.5 Amoun Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment SWOT Analysis
10.1.6 Amoun Pharmaceuticals Recent Developments
10.2 EIPICO
10.2.1 EIPICO Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Basic Information
10.2.2 EIPICO Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Overview
10.2.3 EIPICO Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Market Performance
10.2.4 EIPICO Business Overview
10.2.5 EIPICO Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment SWOT Analysis
10.2.6 EIPICO Recent Developments
10.3 Minapharm Pharmaceuticals
10.3.1 Minapharm Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Basic Information
10.3.2 Minapharm Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Overview
10.3.3 Minapharm Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Market Performance
10.3.4 Minapharm Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment SWOT Analysis
10.3.5 Minapharm Pharmaceuticals Business Overview
10.3.6 Minapharm Pharmaceuticals Recent Developments
10.4 Pharco Pharmaceuticals
10.4.1 Pharco Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Basic Information
10.4.2 Pharco Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Overview
10.4.3 Pharco Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Market Performance
10.4.4 Pharco Pharmaceuticals Business Overview
10.4.5 Pharco Pharmaceuticals Recent Developments
10.5 Alexion Pharmaceuticals
10.5.1 Alexion Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Basic Information
10.5.2 Alexion Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Overview
10.5.3 Alexion Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Market Performance
10.5.4 Alexion Pharmaceuticals Business Overview
10.5.5 Alexion Pharmaceuticals Recent Developments
10.6 Alnylam Pharmaceuticals
10.6.1 Alnylam Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Basic Information
10.6.2 Alnylam Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Overview
10.6.3 Alnylam Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Market Performance
10.6.4 Alnylam Pharmaceuticals Business Overview
10.6.5 Alnylam Pharmaceuticals Recent Developments
10.7 Akari Therapeutics
10.7.1 Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Basic Information
10.7.2 Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Overview
10.7.3 Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Market Performance
10.7.4 Akari Therapeutics Business Overview
10.7.5 Akari Therapeutics Recent Developments
10.8 Amgen
10.8.1 Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Basic Information
10.8.2 Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Overview
10.8.3 Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Market Performance
10.8.4 Amgen Business Overview
10.8.5 Amgen Recent Developments
10.9 CSL Behring
10.9.1 CSL Behring Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Basic Information
10.9.2 CSL Behring Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Overview
10.9.3 CSL Behring Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Market Performance
10.9.4 CSL Behring Business Overview
10.9.5 CSL Behring Recent Developments
10.10 Bioverativ
10.10.1 Bioverativ Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Basic Information
10.10.2 Bioverativ Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Overview
10.10.3 Bioverativ Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Market Performance
10.10.4 Bioverativ Business Overview
10.10.5 Bioverativ Recent Developments
10.11 F. Hoffmann-La Roche Ltd
10.11.1 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Basic Information
10.11.2 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Overview
10.11.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Market Performance
10.11.4 F. Hoffmann-La Roche Ltd Business Overview
10.11.5 F. Hoffmann-La Roche Ltd Recent Developments
10.12 Novartis AG
10.12.1 Novartis AG Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Basic Information
10.12.2 Novartis AG Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Overview
10.12.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Market Performance
10.12.4 Novartis AG Business Overview
10.12.5 Novartis AG Recent Developments
10.13 Amgen Inc
10.13.1 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Basic Information
10.13.2 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Overview
10.13.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Market Performance
10.13.4 Amgen Inc Business Overview
10.13.5 Amgen Inc Recent Developments
10.14 Teva Pharmaceutical
10.14.1 Teva Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Basic Information
10.14.2 Teva Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Overview
10.14.3 Teva Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Market Performance
10.14.4 Teva Pharmaceutical Business Overview
10.14.5 Teva Pharmaceutical Recent Developments
10.15 Abbott
10.15.1 Abbott Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Basic Information
10.15.2 Abbott Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Overview
10.15.3 Abbott Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Product Market Performance
10.15.4 Abbott Business Overview
10.15.5 Abbott Recent Developments
11 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Forecast by Region
11.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Size Forecast
11.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Size Forecast by Country
11.2.3 Asia Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Size Forecast by Region
11.2.4 South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment by Type (2025-2032)
12.1.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment by Type (2025-2032)
12.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Forecast by Application (2025-2032)
12.2.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Sales (K MT) Forecast by Application
12.2.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings